| Mar 21, 2014
| 6:38 PM
Preventing and managing chronic diseases has taken center stage with local health systems trying to control costs and improve outcomes for patients.
Bon Secours Mary Immaculate Hospital offers free diabetes management classes on the second and fourth...
| Jul 12, 2013
| 2:33 PM
Wedding date: May 18, 2013
Her story: Courtney Munzer, 24, grew up in Middletown, Del. She is a pediatric nurse at Children's Hospital of The King's Daughters in Norfolk, Va. Her mother, Deborah Munzer, works at AstraZeneca, a biopharmaceutical company,...
| Jan 8, 2014
| 6:45 PM
The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name...
| Nov 14, 2013
| 4:38 PM
Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
| Oct 1, 2013
| 8:33 AM
Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.
That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
| Apr 29, 2014
| 12:22 PM
Biotechnology company MedImmune said Tuesday it has expanded a bioresearch collaboration it started with the University of System of Maryland.
The Gaithersburg company, a development arm of AstraZeneca, started the partnership with the University of...
| May 5, 2014
| 12:17 PM
Pharmaceutical giant Pfizer Inc. reported its first quarter earnings fell 15% as the company struggled with expiring patents and increasing competition from generic drugs.
The disappointing news added urgency to the New York company's efforts to acquire...
| Sep 26, 2011
| 4:05 AM
CHICAGO (Reuters) - Genetic differences could explain why some 40 percent of people with asthma do not respond to inhaled steroids used to achieve long-term asthma control.
U.S. researchers have found that asthma patients who inherited two copies of a...
| Sep 27, 2011
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
Doctors in the...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
| Sep 3, 2012
| 4:02 AM
CHICAGO (Reuters) - Adults who took inhaled steroids as children to control their asthma may be shorter than they otherwise would have been, but only by a little, U.S. researchers said on Monday.
Results of a long-term asthma study found that children...